You are approaching a major milestone
Clinical manufacturing, commercial readiness, a new CDMO, a regulatory submission or an upcoming inspection can create concentrated quality demands.
Growing life-science companies often reach a point where quality demands increase faster than internal capacity. An experienced consultant can provide targeted support without requiring a permanent organizational change.
Clinical manufacturing, commercial readiness, a new CDMO, a regulatory submission or an upcoming inspection can create concentrated quality demands.
New SOPs, training, CAPA, deviations, change control and supplier processes can become difficult to manage without experienced hands-on Quality leadership.
Repeated deviations, overdue CAPAs, audit observations or unclear ownership can signal a need for an independent assessment.
A fractional or interim quality leader can provide strategy, oversight and execution while a company hires or reorganizes its permanent team.
More CDMOs, CROs, laboratories and suppliers create additional quality oversight responsibilities that may require dedicated expertise.
An independent readiness assessment can identify gaps and help prepare personnel, records and systems before regulators arrive.
For many growing companies, the best fit is someone who can assess the situation, prioritize risks and work directly with the team to get the work completed.